Skip to main content

Editas Medicine, Inc.

EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001650664

In the last 90 days, Editas Medicine, Inc. insiders filed 0 open-market purchases and 5 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $386.3M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Editas Medicine, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of EDIT: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders2262236+12
Shares67.9M985.0K56.4M−10.6M (−15.8%)
Value$503.8M$7.08M$263.3M−$233.3M (−47.0%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (49)

Institutions that held Editas Medicine, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to EDIT in Q2 2024
InstitutionSharesValue% of portfolio
Avidity Partners Management LP816,000$3.81M0.16%
HRT Financial LP298,030$1.39M0.01%
ExodusPoint Capital Management, LP261,381$1.22M0.01%
Mirae Asset Global ETFs Holdings Ltd.205,138$958.6K0.00%
Hennion & Walsh Asset Management, Inc.168,371$786.3K0.04%
Caxton Associates LP128,510$600.1K0.02%
Toroso Investments, LLC117,435$548.4K0.01%
Thrivent Financial for Lutherans85,781$400.0K0.00%
Brevan Howard Capital Management LP79,068$369.2K0.02%
Corebridge Financial, Inc.44,587$208.2K0.00%
Aigen Investment Management, LP33,155$154.8K0.03%
Readystate Asset Management LP29,020$135.5K0.01%
Allspring Global Investments Holdings, LLC20,396$95.2K0.00%
Caption Management, LLC20,000$93.4K0.01%
Laurion Capital Management LP17,648$82.4K0.00%
Pinnacle Wealth Planning Services, Inc.14,735$68.8K0.01%
Aries Wealth Management13,850$64.7K0.02%
Quantinno Capital Management LP12,502$58.4K0.00%
Spectrum Planning & Advisory Services Inc.12,051$57.1K0.06%
Hoylecohen, LLC11,834$55.3K0.00%
CIBC World Markets Inc.11,340$53.0K0.00%
Schonfeld Strategic Advisors LLC11,153$52.1K0.00%
TownSquare Capital, LLC11,092$51.8K0.00%
Bridgefront Capital, LLC10,954$51.2K0.02%
Gibbs Wealth Management10,333$48.3K0.02%
Creative Planning10,090$47.1K0.00%
Koss-Olinger Consulting, LLC10,000$47.0K0.00%
Centiva Capital, LP10,022$46.8K0.00%
Activest Wealth Management4,000$18.7K0.01%
RFP Financial Group LLC1,000$4.67K0.00%
Picton Mahoney Asset Management841$3.00K0.00%
Lindbrook Capital, LLC520$2.43K0.00%
South State Corp.500$2.33K0.00%
CoreCap Advisors, LLC500$2.33K0.00%
Redwood Wealth Management Group, LLC500$2.33K0.00%
Cypress Capital, LLC400$1.87K0.00%
Toth Financial Advisory Corp250$1.17K0.00%
Thurston, Springer, Miller, Herd & Titak, Inc.205$9570.00%
Leonteq Securities AG165$7710.00%
Mather Group, LLC.100$7420.00%
Motco110$5140.00%
Fairfield Financial Advisors, LTD105$4900.00%
Brown, Lisle/Cummings, Inc.65$3040.00%
Smartleaf Asset Management LLC23$1090.00%
Innealta Capital, LLC15$700.00%
Optiver Holding B.V.11$510.00%
Baldwin Brothers Inc8$370.00%
Planning Capital Management Corp7$330.00%
Pacific Capital Wealth Advisors, Inc5$230.00%

Sold out (37)

Institutions that held Editas Medicine, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Not filed for Q2 2024 yet (2)

Institutions that held Editas Medicine, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding EDIT in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG903,257$6.70M
Shell Asset Management Co81,714$382.0K